NEW VIEWS ON THE PATHOPHYSIOLOGY OF PTERIGIUM

Main Article Content

Abstract:

Pterygium is a relatively common disease of the eye surface. Its clinical aspects and treatment methods have been studied for many years, but there are still many uncertainties, as in other diseases. The main pathological mechanisms in the development of pterygium remain interesting to researchers. In addition to the refractive properties of pterygium removal, the role of pterygium in corneal disorders is increasingly recognized in many studies. The association between pterygium and ocular surface neoplasia challenges traditional notions of the safe profile of this disease. The need for a comprehensive clinical classification system has helped to homogenize studies and predict the frequency of recurrence of pterygium after surgical removal. The development of surgical techniques is associated with some complications, the diagnosis and treatment of which are essential for ophthalmic surgeons. According to the review, ultraviolet radiation remains the main risk factor for the development of pterygium. A key part of the clinical evaluation should be to distinguish between typical and atypical pterygium, the latter of which may be associated with increased risk of ocular surface neoplasia. The effect of the pterygium on astigmatism and corneal aberration may require early removal to reduce secondary refractive errors.

Article Details

How to Cite:

Tolibov , A., & Egamov , U. (2024). NEW VIEWS ON THE PATHOPHYSIOLOGY OF PTERIGIUM. Natural Sciences in the Modern World: Theoretical and Practical Research, 3(2), 12–15. Retrieved from https://in-academy.uz/index.php/zdtf/article/view/28014

References:

Reda AM, Shaaban YMM, Saad El-Din SA. Histopathological parameters and important clinical correlates in pterygium. J Ophthalmic Vis Res 2018; 13:110–118. [PMC free article] [PubMed] [Google Scholar]

Minami K, Miyata K, Otani A, et al. Detection of increased corneal asymmetry due to pterygium using multidimensional Fourier series harmonic analysis. Jpn J Ophthalmol 2018; 62:342–348. [PubMed] [Google Scholar]

Minami K, Tokunaga T, Okamoto K, et al. The effect of pterygium size on high-level corneal aberrations is assessed using anterior segment optical coherence tomography. BMC Ophthalmol 2018; 18:166. [PMC free article] [PubMed] [Google Scholar]

Aidenloo NS, Motarjemizadeh Q, Heidarpanah M. Risk factors for pterygium recurrence after limbal-conjunctival autografting: a retrospective, single-center study. Jpn J Ophthalmol 2018; 62:349–356. [PubMed] [Google Scholar]

Kim KW, Kim JC. Current approaches and future directions in the treatment of pterygium. Int J Ophthalmol 2018; 11:709–711. [PMC free article] [PubMed] [Google Scholar]

125 Sabater-Cruz N, Dotti-Boada M, Rios J, et al. Compliance rate of postoperative care and complications after pterygium removal and conjunctival autograft with two different protocols. Eur J Ophthalmol. Epub ahead of print Apr 27, 2020. DOI: 10.1177/1120672120917335. [PubMed] [CrossRef] [Google Scholar]

Kumar S, Singh R. Pterygium excision and conjunctival autograft: a comparative study of the techniques. Oman J Ophthalmol 2018; 11:124–128. [PMC free article] [PubMed] [Google Scholar]

Ucar F, Cetinkaya S. Results of preoperative topical brimonidine in pterygium surgery. J Ocul Pharmacol Ther 2020; 36:234–237. [PubMed] [Google Scholar]

Sun Y, Zhang B, Jia X, et al. Efficacy and safety of bevacizumab in the treatment of pterygium: an updated meta-analysis of randomized controlled trials. J Ophthalmol 2018; 2018: 4598173. [PMC free article] [PubMed] [Google Scholar]

Zhang Q, Bao N, Liang K, et al. Adjuvant use of cyclosporine A in the treatment of primary pterygium: a systematic review and meta-analysis. Cornea 2018; 37:1000–1007. [PubMed] [Google Scholar]